ASN
NMRA icon

Advisory Services Network’s Neumora Therapeutics NMRA Stock Holding History

Advisory Services Network’s Portfolio NMRA Stock Details NMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-200
Closed -$3.41K – 2877
2023
Q4 		$3.41K Buy
+200
New +$2.46K ﹤0.01% 3241

Other funds holding NMRA

SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Advisory Services Network's NMRA Position: Q1 2024 in Review

Advisory Services Network sold out of Neumora Therapeutics (NMRA) in Q1 2024, closing a stake of 200 shares — an estimated $3.41K sold.

Advisory Services Network first reported a position in NMRA in Q4 2023 and held it in 1 quarter. The position peaked at $3.41K in Q4 2023. 88 funds tracked by Wall St. Rank hold NMRA as of Q1 2024.

  • Advisory Services Network reported no remaining Neumora Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Advisory Services Network sold 200 Neumora Therapeutics shares in Q1 2024, an estimated $3.41K.
  • Advisory Services Network first reported a position in Neumora Therapeutics in Q4 2023 and held it in 1 quarter.
  • Advisory Services Network's Neumora Therapeutics position peaked at $3.41K in Q4 2023.
  • 88 funds tracked by Wall St. Rank held Neumora Therapeutics as of Q1 2024.

Based on Advisory Services Network's 13F filing for Q1 2024, filed 6 May 2024.